Karun Kaushik and Selin Kocalar unexpectedly found themselves in a position to raise a Series A round for their AI compliance startup, Delve, after experiencing rapid growth and attracting numerous customers. The company, which specializes in automating regulatory compliance using AI agents, recently closed a $32 million Series A round at a $300 million valuation, with Insight Partners leading the investment. Delve’s valuation has seen a significant increase from its previous round, and its customer base has grown substantially. The founders, who met at MIT, initially worked on an AI-powered medical scribe before pivoting to focus on helping companies achieve HIPAA compliance more efficiently.
Delve’s Approach to Compliance Automation
Delve’s innovative approach to compliance automation involves utilizing AI agents to streamline manual processes, such as collecting evidence, writing reports, and tracking configuration changes. This technology not only enhances compliance workflows but also has the potential to automate a billion hours of other back-office work in the future. Insight Partners’ investment in Delve reflects their belief in the company’s long-term vision and potential to modernize organizational operations through compliance automation.
Positioning for Future Growth
While Delve faces competition from other AI companies and general-purpose agents, Kocalar emphasizes the importance of the company’s domain-specific knowledge and deep expertise in compliance. As AI technology continues to advance, Delve is focused on evolving alongside it and incorporating new regulations into its platform. This commitment to staying ahead of the curve and offering tailored solutions sets Delve apart in the rapidly changing landscape of compliance automation.
